These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

6106 related articles for article (PubMed ID: 3493226)

  • 1. Production of stable cytolytic T-cell clones directed against autologous human melanoma.
    Hérin M; Lemoine C; Weynants P; Vessière F; Van Pel A; Knuth A; Devos R; Boon T
    Int J Cancer; 1987 Mar; 39(3):390-6. PubMed ID: 3493226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigenic heterogeneity of a human melanoma tumor detected by autologous CTL clones.
    Degiovanni G; Lahaye T; Hérin M; Hainaut P; Boon T
    Eur J Immunol; 1988 May; 18(5):671-6. PubMed ID: 2967757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity.
    de Vries JE; Spits H
    J Immunol; 1984 Jan; 132(1):510-9. PubMed ID: 6197458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytolytic T-cell clones against an autologous human melanoma: specificity study and definition of three antigens by immunoselection.
    Knuth A; Wölfel T; Klehmann E; Boon T; Meyer zum Büschenfelde KH
    Proc Natl Acad Sci U S A; 1989 Apr; 86(8):2804-8. PubMed ID: 2784858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presence on a human melanoma of multiple antigens recognized by autologous CTL.
    Van den Eynde B; Hainaut P; Hérin M; Knuth A; Lemoine C; Weynants P; van der Bruggen P; Fauchet R; Boon T
    Int J Cancer; 1989 Oct; 44(4):634-40. PubMed ID: 2529220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphocytes cytotoxic to uveal and skin melanoma cells from peripheral blood of ocular melanoma patients.
    Kan-Mitchell J; Liggett PE; Harel W; Steinman L; Nitta T; Oksenberg JR; Posner MR; Mitchell MS
    Cancer Immunol Immunother; 1991; 33(5):333-40. PubMed ID: 1831067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysis of human melanoma cells by autologous cytolytic T cell clones. Identification of human histocompatibility leukocyte antigen A2 as a restriction element for three different antigens.
    Wölfel T; Klehmann E; Müller C; Schütt KH; Meyer zum Büschenfelde KH; Knuth A
    J Exp Med; 1989 Sep; 170(3):797-810. PubMed ID: 2788708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clonal analysis of cytotoxic T-lymphocyte response to autologous human metastatic melanoma.
    Anichini A; Fossati G; Parmiani G
    Int J Cancer; 1985 May; 35(5):683-9. PubMed ID: 3158614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigens recognized on a melanoma cell line by autologous cytolytic T lymphocytes are also expressed on freshly collected tumor cells.
    Degiovanni G; Hainaut P; Lahaye T; Weynants P; Boon T
    Eur J Immunol; 1990 Aug; 20(8):1865-8. PubMed ID: 2209693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of HLA class I antigens in recognition of melanoma cells by tumor-specific cytotoxic T lymphocytes. Evidence for shared tumor antigens.
    Darrow TL; Slingluff CL; Seigler HF
    J Immunol; 1989 May; 142(9):3329-35. PubMed ID: 2785141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-B-restricted, CD8+ cytolytic human T cell clones derived from a melanoma-invaded lymph node.
    Nakashima M; Watanabe T; Koprowski H; Steplewski Z
    Hybridoma; 1996 Apr; 15(2):147-54. PubMed ID: 8743295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular immune response to human renal-cell carcinomas: definition of a common antigen recognized by HLA-A2-restricted cytotoxic T-lymphocyte (CTL) clones.
    Bernhard H; Karbach J; Wölfel T; Busch P; Störkel S; Stöckle M; Wölfel C; Seliger B; Huber C; Meyer zum Büschenfelde KH
    Int J Cancer; 1994 Dec; 59(6):837-42. PubMed ID: 7989126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diversity of the cytotoxic melanoma-specific immune response: some CTL clones recognize autologous fresh tumor cells and not tumor cell lines.
    Dufour E; Carcelain G; Gaudin C; Flament C; Avril MF; Faure F
    J Immunol; 1997 Apr; 158(8):3787-95. PubMed ID: 9103444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clonal analysis of cytotoxic and regulatory T cell responses against human melanoma.
    Mukherji B; Guha A; Chakraborty NG; Sivanandham M; Nashed AL; Sporn JR; Ergin MT
    J Exp Med; 1989 Jun; 169(6):1961-76. PubMed ID: 2471770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Precursor frequency analysis of human cytolytic T lymphocytes directed against autologous melanoma cells.
    Coulie PG; Somville M; Lehmann F; Hainaut P; Brasseur F; Devos R; Boon T
    Int J Cancer; 1992 Jan; 50(2):289-97. PubMed ID: 1730522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melanoma cells and normal melanocytes share antigens recognized by HLA-A2-restricted cytotoxic T cell clones from melanoma patients.
    Anichini A; Maccalli C; Mortarini R; Salvi S; Mazzocchi A; Squarcina P; Herlyn M; Parmiani G
    J Exp Med; 1993 Apr; 177(4):989-98. PubMed ID: 8459226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human T cell clones exerting multiple cytolytic activities show heterogeneity in susceptibility to inhibition by monoclonal antibodies.
    van de Griend RJ; Giphart MJ; Van Krimpen BA; Bolhuis RL
    J Immunol; 1984 Sep; 133(3):1222-9. PubMed ID: 6205072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxic T lymphocyte clones from peripheral blood and from tumor site detect intratumor heterogeneity of melanoma cells. Analysis of specificity and mechanisms of interaction.
    Anichini A; Mazzocchi A; Fossati G; Parmiani G
    J Immunol; 1989 May; 142(10):3692-701. PubMed ID: 2469723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell receptor (TCR) structure of autologous melanoma-reactive cytotoxic T lymphocyte (CTL) clones: tumor-infiltrating lymphocytes overexpress in vivo the TCR beta chain sequence used by an HLA-A2-restricted and melanocyte-lineage-specific CTL clone.
    Sensi M; Salvi S; Castelli C; Maccalli C; Mazzocchi A; Mortarini R; Nicolini G; Herlyn M; Parmiani G; Anichini A
    J Exp Med; 1993 Oct; 178(4):1231-46. PubMed ID: 8376931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD4(+), HLA class I-restricted, cytolytic T-lymphocyte clone against primary malignant melanoma cells.
    Somasundaram R; Robbins P; Moonka D; Loh E; Marincola F; Patel A; Guerry D; Herlyn D
    Int J Cancer; 2000 Jan; 85(2):253-9. PubMed ID: 10629086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 306.